SCHEMBL29795172

SCHEMBL29795172

C=CCN(C)CCc1c[nH]c2ccc(OC)cc12

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 7/20 0.80
HTR2A P28223 6/20 0.80
HTR1A P08908 5/20 0.80
HTR1D P28221 4/20 0.80
HTR1B P28222 4/20 0.80
HTR2C P28335 4/20 0.80
HTR7 P34969 4/20 0.80
HTR2B P41595 4/20 0.80
HTR1E P28566 3/20 0.80
HTR5A P47898 3/20 0.80
SLC6A4 P31645 3/20 0.80
ADRA2A P08913 2/20 0.80
ADRA2B P18089 2/20 0.80
ADRA2C P18825 2/20 0.80
HRH1 P35367 2/20 0.80
DRD3 P35462 2/20 0.80
OPRK1 P41145 2/20 0.80
SLC6A3 Q01959 2/20 0.80
SIGMAR1 Q99720 2/20 0.80
SLC6A2 P23975 1/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20970958 1.00 HTR6 (0.80) HTR6HTR2AHTR1AHTR1DHTR1B
Fumaric Acid SCHEMBL30729598 0.92 HTR1A (0.69) HTR6HTR2AHTR1AHTR1DHTR1B
Fumaric Acid SCHEMBL26970874 0.92 HTR1A (0.69) HTR6HTR2AHTR1AHTR1DHTR1B
SCHEMBL27084928 0.90 HTR6 (0.70) HTR6HTR2AHTR1AHTR1DHTR1B
SCHEMBL15162217 0.89 HTR1A (1.00) HTR6HTR2AHTR1AHTR1DHTR1B
SCHEMBL29404034 0.89 HTR1A (1.00) HTR6HTR2AHTR1AHTR1DHTR1B
Hydrochloric Acid SCHEMBL27845587 0.88 HTR1A (0.98) HTR6HTR2AHTR1AHTR1DHTR1B
SCHEMBL23375635 0.86 HTR1D (0.73) HTR6HTR2AHTR1AHTR1DHTR1B
SCHEMBL30630317 0.86 HTR1D (0.73) HTR6HTR2AHTR1AHTR1DHTR1B
SCHEMBL30630391 0.86 HTR1A (0.89) HTR6HTR2AHTR1AHTR1DHTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4615444-A1 TRYPTAMINE FORMULATIONS AND USES THEREOF Natural Medtech Pty Ltd (AU) 2025-09-17 EP disclosed
WO-2024098098-A1 TRYPTAMINE FORMULATIONS AND USES THEREOF Natural MedTech Pty Ltd (AU) 2024-05-16 WO disclosed
WO-2023283386-A2 SAFER PSYCHOACTIVE COMPOSITIONS ARCADIA MEDICINE, INC. (US) 2023-01-12 WO disclosed
WO-2022109050-A1 COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS BEXSON BIOMEDICAL, INC. (US) 2022-05-27 WO disclosed